Last week, a young woman with sickle cell anemia became the first person in the United States to have her cells altered with CRISPR gene editing technology. Here’s what that means for the future treatment of genetic diseases.
Doctors altered a person’s genes with CRISPR for the first time in the U.S. Here’s what could be next
Posted in bioengineering, biotech/medical, genetics